ViewRay prices $150m offering

ViewRay (NSDQ:VRAY) yesterday priced an upcoming offering looking to raise $150 million.

The Cleveland-based company plans to float approximately 16.2 million shares of common stock at $9.25 per share, bringing in $150 million gross before offering-related payments.

The offering, slated to close on August 17, will also include a 30-day underwriter’s option to purchase an additional 2.4 million shares at the same price.

ViewRay said it plans to use funds raised to support working capital and general corporate purposes, including R&D, clinical trials, capital expenditures and infrastructure expenses, according to a press release.

Late last month, ViewRay said that it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO.

Building Better Companies at DeviceTalks Minnesota DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as: Navigating the path to market Reimbursement Winning regulatory approval Corporate culture Entering global markets Leadership Join industry leaders and medical device professionals at the most awaited medtech conference of the year, DeviceTalks Minnesota. Use code SAVE15 to save 15%! REGISTER NOW